According to recent retrospective data, the median overall survival (OS) of patients with IDH-mutant astrocytoma is 78.5–161.0 months, whereas the median OS of patients with IDH-wildtype glioblastoma is only 22.0–27.2 months [27]. Here, IDH1 is linked to astrocytoma (excluding glioblastoma).